First Department of Pediatrics, Semmelweis University, Budapest H-1083, Hungary.
Immunol Lett. 2010 Sep 6;133(1):35-41. doi: 10.1016/j.imlet.2010.06.009. Epub 2010 Jul 13.
Kv1.3 and IKCa1 potassium channels participate in the maintenance of calcium-influx during lymphocyte activation. Kv1.3 channels have a prominent role in specific T cell subsets, presenting a possible target for selective immunomodulation. We investigated the impact of Kv1.3 and IKCa1 channel inhibitors on calcium-influx characteristics in human T cells in type 1 diabetes mellitus. We isolated lymphocytes from 9 healthy and 9 type 1 diabetic individuals and measured the alteration of calcium-influx with flow cytometry in the Th1, Th2, CD4 and CD8 subsets after treatment of samples with specific channel inhibitors. Our results indicate an increased reactivity of type 1 diabetes lymphocytes, which is correlated to their increased sensitivity to Kv1.3 channel inhibition. However, the contribution of Kv1.3 channels to calcium flux is not exclusive for a specific lymphocyte subset as previous reports suggest, but is characteristic for each subset investigated. Therefore, the proposed inhibition of Kv1.3 channels as a novel therapeutic approach for the treatment of type 1 diabetes mellitus may have a major effect on overall lymphocyte function in this disease.
Kv1.3 和 IKCa1 钾通道参与淋巴细胞激活过程中钙内流的维持。Kv1.3 通道在特定的 T 细胞亚群中起着重要作用,为选择性免疫调节提供了一个可能的靶点。我们研究了 Kv1.3 和 IKCa1 通道抑制剂对 1 型糖尿病患者 T 细胞钙内流特征的影响。我们从 9 名健康个体和 9 名 1 型糖尿病个体中分离出淋巴细胞,并在使用特定通道抑制剂处理样本后,通过流式细胞术测量 Th1、Th2、CD4 和 CD8 亚群中钙内流的变化。我们的结果表明,1 型糖尿病患者的淋巴细胞反应性增强,这与其对 Kv1.3 通道抑制的敏感性增加有关。然而,正如先前的报道所表明的,Kv1.3 通道对钙流的贡献并非特定于特定的淋巴细胞亚群,而是每个研究的亚群的特征。因此,拟议的抑制 Kv1.3 通道作为治疗 1 型糖尿病的一种新的治疗方法,可能对该疾病中整体淋巴细胞功能产生重大影响。